0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 13686106 2024-04-01 2025-03-31 13686106 2025-03-31 13686106 2024-03-31 13686106 2023-04-01 2024-03-31 13686106 2024-03-31 13686106 2023-03-31 13686106 bus:Director1 2024-04-01 2025-03-31 13686106 core:WithinOneYear 2025-03-31 13686106 core:WithinOneYear 2024-03-31 13686106 bus:Micro-entities 2024-04-01 2025-03-31 13686106 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 13686106 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 13686106 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13686106 bus:FullAccounts 2024-04-01 2025-03-31
COMPANY REGISTRATION NUMBER: 13686106
DOCTOR REJUVENATE LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
31 March 2025
DOCTOR REJUVENATE LIMITED
STATEMENT OF FINANCIAL POSITION
31 March 2025
2025
2024
£
£
£
Fixed assets
2,734
3,037
-------
-------
Current assets
31,827
39,270
Creditors: amounts falling due within one year
12,417
13,713
--------
--------
Net current assets
19,410
25,557
--------
--------
Total assets less current liabilities
22,144
28,594
Accruals and deferred income
600
600
--------
--------
21,544
27,994
--------
--------
Capital and reserves
21,544
27,994
--------
--------
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 31 July 2025 , and are signed on behalf of the board by:
Dr J Stokes
Director
Company registration number: 13686106
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Numeric House, 98 Station Road, Sidcup, DA15 7BY, UK.